Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine®
Following this major achievement, apoQlar is now raising a Series A round, its first ever fundraising campaign, to scale VSI Holomedicine as the foundation of modern surgical care.
- Following this major achievement, apoQlar is now raising a Series A round, its first ever fundraising campaign, to scale VSI Holomedicine as the foundation of modern surgical care.
- VSI HoloMedicine gives surgeons an almost "x-ray vision" perspective in surgical planning processes using 3D holographic technology.
- apoQlar developed an affordable medical metaverse technology, VSI HoloMedicine, that brings the crucial third dimension to surgical planning, remote consultation, patient education and medical training.
- VSI HoloMedicine holds FDA 510(k), CE Class I and HSA Class A medical certifications for clinical use in 30 countries.